Stocktoria
Q32 Bio Inc. QTTB
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-03-28
Q32 Bio Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.7M | $0 | -$6.7M | $3.2M | $34.0M | $2.7M | $1.7M | $5.3M | — |
| R&D expense | $19.2M | $48.1M | $31.7M | $98.4M | $93.1M | $100.4M | $89.4M | $47.9M | $21.4M |
| Operating income | $16.9M | -$66.1M | -$48.3M | -$133.3M | -$95.9M | -$130.3M | -$109.9M | -$59.9M | -$29.7M |
| Income tax | $0 | $21,000 | $318,000 | $715,000 | $0 | $0 | $0 | $0 | $0 |
| Net income | $29.8M | -$47.7M | -$53.7M | -$5.0M | -$95.8M | -$128.7M | -$103.9M | -$55.6M | -$30.0M |
| EPS (diluted) | $2.42 | $-6.58 | $-153.96 | $-0.09 | $-1.73 | — | — | — | — |
| Operating cash flow | -$33.5M | -$67.7M | -$18.7M | -$113.7M | -$109.8M | -$94.3M | -$91.4M | -$42.6M | $6.5M |
| Free cash flow | -$33.5M | -$67.8M | -$18.7M | -$114.9M | -$112.1M | -$98.1M | -$113.2M | -$67.5M | $4.5M |
| Cash & equivalents | $48.3M | $78.0M | $25.6M | $34.0M | $108.4M | $217.4M | $53.8M | $38.2M | $51.6M |
| Total assets | $61.8M | $92.3M | $47.1M | $228.5M | $211.7M | $263.7M | $310.6M | $259.1M | $137.5M |
| Total liabilities | $19.8M | $86.7M | $118.5M | $50.5M | $42.1M | $67.7M | $52.1M | $62.7M | $39.2M |
| Shareholders' equity | $42.0M | $5.7M | -$182.9M | -$130.7M | $169.7M | $196.0M | $258.5M | $196.4M | -$39.5M |
Growth · year-over-year · Revenue CAGR 39.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -307.3% | -90.6% | +1157.3% | +62.2% | -68.7% | — | — |
| Free cash flow growth | — | — | — | — | — | — | — | -1593.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.